Will the murder of a health insurance CEO cause an industry reckoning?
UnitedHealthcare CEO Brian Thompson was shot and killed in what police believe was a targeted attack
The insurance industry was rattled on Dec. 4 by the death of UnitedHealthcare CEO Brian Thompson. The 50-year-old was gunned down in Manhattan on his way to a health care conference; police believe his death was a targeted assassination, with New York Police Commissioner Jessica Tisch calling it a "premeditated, preplanned, targeted attack."
In the wake of Thompson's death, widespread anger began brewing — not directed toward the suspected shooter, Luigi Mangione, but rather at Thompson and his company. Dozens of stories began circulating online of people whose insurance claims had reportedly been denied by UnitedHealthcare. While insurance companies try to keep these figures hidden, Forbes estimates that UnitedHealthcare refuses about one-third of submitted claims. Thompson's alleged shooter reportedly wrote the words "delay," "deny" and "depose" on the bullets, a possible reference to the phrase "delay, deny, defend" commonly used by insurance industry critics.
Now some are left wondering if Thompson's shooting will lead to change in the insurance industry, or if there will be a reckoning among the other CEOs of similar companies.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What did the commentators say?
While all insurance companies face criticism, the UnitedHealthcare CEO's "shocking shooting has put new focus on the firm, its reputation and history," said Jeremy Olson at The Minnesota Star Tribune. Thompson's killing "became an opportunity for some to publicly vent about UnitedHealthcare," Wendell Potter, a former Cigna vice president, said to the Star Tribune, largely because "nothing like this has ever happened before."
Between the "condemnation of violence and dark humor, celebratory memes and outright violent rhetoric, comments on social media highlight the deep and often unpleasant connection Americans have with their own health system," Jessica Glenza said at The Guardian. People appear to be "seeing violence as the more normal tool, or acceptable tool, to resolve what should be straightforward civil disputes resolved in nonviolent ways," Robert Pape, the director of the University of Chicago's security and threats project, said to the outlet.
The incident has "prompted patients and family members to weigh in publicly, sharing wrenching horror stories of insurance claim reimbursement stagnation and denials," said Dionne Searcey and Madison Malone Kircher at The New York Times. However, Thompson was "one of the few executives who wanted to do something about it," and "workers at the company had been aware for years that members were unhappy," a UnitedHealthcare employee said to the outlet.
The insurance industry is "now watching the unfolding investigation with increasing concern, especially as its contentious business practices take center stage in the troubling situation," said Katherine Davis at Crain's Chicago Business. Insurance executives are aware that their "practices are creating a lot of friction, and we're more than happy to work through those points of abrasion, but we can't do that if people are fearing for their lives," Laura Minzer, the CEO of the Illinois Life & Health Insurance Council, said to Crain's. But "maybe out of this tragedy, comes an opportunity to have a more honest conversation about where the points of concern are."
What next?
If the attack is confirmed to be related to insurance policies, it "could cause companies in the sector to make some changes," Ron Culp, a DePaul University public relations consultant, said to Crain's. Insurance companies "having to make sometimes life-or-death decisions will need to rethink how they communicate with customers," and "empathy and potential alternative solutions will play greater roles."
The shooting might also "deter highly qualified candidates from aspiring to the CEO position, particularly at polarizing companies, like, say, X, or in polarizing industries like insurance or armament manufacturing," said Fortune.
Some are also wondering if the apparent indifference around Thompson's killing is part of a trend that's here to stay. Many comments online "in support of the suspect have been tinged with class rage and anti-corporate venom," said The Wall Street Journal. While this type of class anger is not new, the "current outpouring is on a grander scale and fueled by social media." To some, the shooting appears to be an "expression of the same broad-based populist eruption that has shaken American life in recent years."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and other news. Justin has also freelanced for outlets including Collider and United Press International.
-
Nosferatu: Lily-Rose Depp stars in 'seductively frightening' horror reboot
The Week Recommends Visually stunning remake of the German expressionist classic
By The Week UK Published
-
Gobsmacked!: Ben Yagoda charts the 'British invasion of American English'
The Week Recommends New book shows how British words such as 'kerfuffle' have filtered into American usage
By The Week UK Published
-
The biggest music tours coming to the UK in 2025
The Week Recommends From Sabrina Carpenter to Bruce Springsteen, these are the most hotly anticipated acts
By Irenie Forshaw, The Week UK Published
-
Walking pneumonia cases are picking up pace
The explainer Another respiratory illness to be wary of
By Devika Rao, The Week US Published
-
How can the UK solve the adult social care crisis?
Today's Big Question New commission announced to turn our buckling care sector around: yet more delay or finally a way forward?
By Elizabeth Carr-Ellis, The Week UK Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
The future of fluoridated water is up for debate
The Explainer The oral benefits are watery
By Devika Rao, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Polycystic ovary syndrome: what it is, how it's treated and why it's often misunderstood
The Explainer PCOS affects millions, but there is still no cure outside of treating symptoms separately
By Theara Coleman, The Week US Published
-
The growing list of conditions weight-loss drugs could help with
The Explainer Ozempic and similar drugs have been linked to possibly helping diseases beyond diabetes and obesity. Are they miracle drugs?
By Theara Coleman, The Week US Published